Akebia Therapeutics Inc (AKBA:NASDAQ)
$1.295 0.08 (7.02%)
Analysed Akebia Therapeutics Inc (AKBA:NASDAQ) News Sources
Akebia Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial and Pipeline Highlights
Yahoo Finance
Akebia Therapeutics Q4 Earnings Call Highlights
Yahoo Finance
Why Akebia Therapeutics, Inc.’s (AKBA) Stock Is Up 6.36%
American Association of Individual Investors
Akebia outlines 2026 pipeline expansion and expects Vafseo data catalysts in $1B dialysis market
Seeking Alpha
Ardelyx (ARDX) reports break-even earnings for Q4
Zacks Investment Research on MSN
Hyderabad Biotech Utopia Therapeutics Secures US Patent for Immunotherapy-Based Obesity Vaccine
Medical Dialogues
MAIA Pharmaceuticals Selected by Asahi Kasei Pharma to Advance Teribone™ for US Osteoporosis Patients
Medindia
What is the current price of Akebia Therapeutics Inc (AKBA:NASDAQ)?
The current price of Akebia Therapeutics Inc (AKBA:NASDAQ) is $1.295.
Akebia Therapeutics Inc (AKBA:NASDAQ) absolute price change since previous trading day?
The absolute price change of Akebia Therapeutics Inc (AKBA:NASDAQ) since the previous trading day is $0.08.
Akebia Therapeutics Inc (AKBA:NASDAQ) percentage price change since previous trading day?
The percentage price change of Akebia Therapeutics Inc (AKBA:NASDAQ) since the previous trading day is 7.02%.
What is This Week's average sentiment score for Akebia Therapeutics Inc (AKBA:NASDAQ)?
This Week's average sentiment score for Akebia Therapeutics Inc (AKBA:NASDAQ) is 81 out of 100.
What is This Week's average sentiment for Akebia Therapeutics Inc (AKBA:NASDAQ)?
This Week's sentiment for Akebia Therapeutics Inc (AKBA:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.